Wockhardt received tentative approval for the Abbreviated New Drug Application from the US FDA for the Fexofenadine Hydrochloride oral tablets in multiple strengths of 30 mg, 60 mg and 180 mg.
Wockhardt received tentative approval for the Fexofenadine Hydrochloride